CollinsP., RosanoG.M.C., SarrelP.M.: Estradiol-17β attenuates acetylcholine-induced coronary arterial constriction in women but not men with coronary heart disease. Circulation92: 24–30, 1995
5.
CollinsP., ShayJ., JiangC.: Nitric oxide accounts for dose-dependent estrogen-mediated coronary relaxation following acute estrogen withdrawal. Circulation90: 1964–1968, 1994
6.
FurchgottR.F., ZawadzkiJ.V.: The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature288: 373–376, 1980
7.
FutoJ., ShayJ., HoltJ.: Estrogen and progesterone withdrawal increases cerebral vasoreactivity to serotonin in rabbit basilar artery. Life Sci50: 1165–1172, 1992
8.
GangerK.F., VyasS., WhiteheadM.: Pulsatility index in internal carotid artery in relation to transdermal oestradiol and time since menopause. Lancet338: 839–842, 1991
9.
GilliganD.M., QuyyumlA.A., CannonROIII: Effects of physiological levels of estrogen on coronary vasomotor function in postmenopausal women. Circulation89: 2545–2551, 1994
10.
GodslandI.F., WynnV., CrookD.: Sex, plasma lipoproteins, and atherosclerosis: Prevailing assumptions and outstanding questions. Am Heart J114: 1467–1503, 1987
11.
GorodeskiG.I., YangT., LevyM.N.: Effects of estrogen in vivo on coronary vascular resistance in perfused rabbit hearts. Am J Physiol269: 1333–1338, 1995
12.
HanS.Z., KarakiH., OuchiY.: 17β-Estradiol inhibits Ca2+ influx and Ca2+ release by thromboxane A2 in porcine coronary artery. Circulation91: 2619–2626, 1995
13.
HenryP.D., BentleyK.I.: Suppression of atherogenesis in cholesterol-fed rabbit treated with nifedipine. J Clin Invest68: 1366–1369, 1981
14.
JiangC., Poole-WilsonP.A., SarrelP.M.: Effect of 17β-oestradiol on contraction, Ca2+ current and intracellular free Ca2+ In guinea-pig isolated cardiac myocytes. Br J Pharmacol106: 739–745, 1992
15.
JiangC., SarrelP.M., LindsayD.C.: Endothelium-independent relaxation of rabbit coronary artery by 17β-oestradiol in vitro. Br J Pharmacol104: 1033–1037, 1991
16.
LichtlenP.R., HugenholtzP.G., RafflenbeulW.: Retardation of angiographic progression of coronary artery disease by nifedipine. Lancet335: 1109–1113, 1990
17.
MagnessR.R., RosenfeldC.R.: Local and systemic estradiol-17 beta: Effects on uterine and systemic vasodilation. Am J Physiol256: E536–E542, 1989
18.
MartinW., VillaniG.M., JothianandanD.: Selective blockade of endothelium-dependent and glyceryl trinitrate-induced relaxation by hemoglobin and by methylene blue in the rabbit aorta. J Pharmacol Exp Ther232: 708–716, 1985
19.
MillerV.M., GisclardV., VanhoutteP.M.: Modulation of endothelium-dependent and vascular smooth muscle responses by estrogens. Phlebologie224: 19–22, 1988
20.
MüggeA., RiedelM., BartonM.: Endothelium independent relaxation of human coronary arteries by 17beta-oestradiol in vitro. Cardiovasc Res27: 1939–1942, 1993
21.
PalmerR.M., FerrigeA.G., MoncadaS.: Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature327: 524–526, 1987
22.
RaddinoR., MancaC., PoliE.: Effects of 17 beta-estradiol on the isolated rabbit heart. Arch Int Pharmacodyn Ther281: 57–65, 1986
23.
ReisS.E., GlothST., BlumenthalR.S.: Ethinyl estradiol acutely attenuates abnormal coronary vasomotor responses to acetylcholine in postmenopausal women. Circulation89: 52–60, 1994
24.
RosanoG.M.C., SarrelP.M., Poole-WilsonP.A.: Beneficial effect of oestrogen on exercise-induced myocardial ischaemia in women with coronary artery disease. Lancet342: 133–136, 1993
25.
RosettaL.: Female reproductive dysfunction and intense physical training (review). Oxford Reviews of Reproductive Biology15: 113–141, 1993
Schray-UtzB., ZeiherA.M., BusseR.: Expression of constitutive NO synthase in cultured endothelial cells is enhanced by 17β-estradiol (abstract). Circulation88: 1–80, 1993
Van BurenG., YangD., ClarkK.E.: Estrogen-induced uterine vasodilatation is antagonized by L-nitroarginine methyl ester, an inhibitor of nitric oxide synthesis. Am J Obstet Gynecol16: 828–833, 1992
30.
VolterraniM., RosanoG.M.C., CoatsA.: Estrogen acutely Increases peripheral blood flow in postmenopausal women. Am J Med99: 119–122, 1995
31.
WatersD., LesperanceJ., FrancetichM.: A controlled clinical trial to assess the effect of a calcium channel blocker on the progression of coronary atherosclerosis. Circulation82: 1940–1953, 1990
32.
WeinerC.P., LizasoainI., BaylisS.A.: Induction of calcium-dependent nitric oxide synthases by sex hormones. Proc Natl Acad Sci USA91: 5212–5216, 1994
